Vectormune ND

Authorised

This medicine is authorised for use in the European Union

Newcastle disease and Marek’s disease vaccine (live recombinant)

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Vectormune ND : EPAR - Summary for the public

Reference Number: EMA/464718/2015

Product information

Vectormune ND : EPAR - Product Information

Vectormune ND : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Vectormune ND
• International non-proprietary name (INN) or common name:
  Newcastle disease and Marek’s disease vaccine (live recombinant)

Pharmacotherapeutic group

• Immunologicals for aves
• Live viral vaccines
• Domestic fowl

Authorisation details

• EMA product number:
  EMEA/V/C/003829

Assessment history

Changes since initial authorisation of medicine

Vectormune ND : EPAR - Procedural steps taken and scientific information after authorisation

Vectormune ND-V-C-003829-II-0007 : EPAR - Assessment Report - Variation

Adopted Reference Number: EMA/72864/2018

CVMP post-authorisation summary of positive opinion for Vectormune ND (II/0007)

Adopted Reference Number: EMA/CVMP/739766/2017

Initial marketing authorisation documents

Vectormune ND : EPAR - Public assessment report

Adopted Reference Number: EMA/469665/2015

CVMP summary of positive opinion for Vectormune ND

Adopted Reference Number: EMA/CVMP/354791/2015